Английская Википедия:Immunomedics

Материал из Онлайн справочника
Версия от 13:04, 25 марта 2024; EducationBot (обсуждение | вклад) (Новая страница: «{{Английская Википедия/Панель перехода}} {{short description|Former pharmaceutical company}} {{Infobox company | industry = Biotechnology | parent = Gilead Sciences | founded = {{start date and age|1982|07}} | defunct = {{end date and age|2020|10|23}} | founder = David M. Goldenberg | location = Morris Plains, New Jersey }} '''Immunomedics''' was a biotechnology company focused on the development of antibo...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Infobox company

Immunomedics was a biotechnology company focused on the development of antibody-drug conjugates for the treatment of cancer. In 2020, the company was acquired by Gilead Sciences.[1]

History

Immunomedics was founded in July 1982 by David M. Goldenberg.[2]

Michael Pehl was named CEO in December 2017 but left due to personal reasons in February 2019.[3] At that time, Dr. Behzad Aghazadeh was named Executive Chairman.[4]

In October 2020, Gilead Sciences acquired the company.[1] In March 2022, Gilead announced the closing of the former Immunomedics facility in Morris Plains. [5]

Products

References

Шаблон:Reflist

Шаблон:Authority control